Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib - MD Linx

Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib  MD Linx

Comments

Popular posts from this blog

Medical Review Board

Cases of hand, foot and mouth disease on the rise among Manitoba kids - Global News